Abstract:Glioblastoma, a grade IV astrocytoma, is regarded as the most aggressive primary brain tumour with an overall median survival of 16.0 months following the standard treatment regimen of surgical resection, followed by radiotherapy and chemotherapy with temozolomide. Despite such intensive treatment, the tumour almost invariably recurs. This poor prognosis has most commonly been attributed to the initiation, propagation, and differentiation of cancer stem cells. Despite the unprecedented advances in biomedical research over the last decade, the current in vitro models are limited at preserving the inter- and intra-tumoural heterogeneity of primary tumours. The ability to understand and manipulate complex cancers such as glioblastoma requires disease models to be clinically and translationally relevant and encompass the cellular heterogeneity of such cancers. Therefore, brain cancer research models need to aim to recapitulate glioblastoma stem cell function, whilst remaining amenable for analysis. Fortunately, the recent development of 3D cultures has overcome some of these challenges, and cerebral organoids are emerging as cutting-edge tools in glioblastoma research. The opportunity to generate cerebral organoids via induced pluripotent stem cells, and to perform co-cultures with patient-derived cancer stem cells (GLICO model), has enabled the analysis of cancer development in a context that better mimics brain tissue architecture. In this article, we review the recent literature on the use of patient-derived glioblastoma organoid models and their applicability for drug screening, as well as provide a potential workflow for screening using the GLICO model. The proposed workflow is practical for use in most laboratories with accessible materials and equipment, a good first pass, and no animal work required. This workflow is also amenable for analysis, with separate measures of invasion, growth, and viability.

Assembly of glioblastoma tumoroids and cerebral organoids: a 3D in vitro model for tumor cell invasion

Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion

Modeling glioblastoma tumor progression via CRISPR-engineered brain organoids

Modeling the Precise Interaction of Glioblastoma with Human Brain Region-Specific Organoids

Tmic-34. Infiltrative Behavior Of Patient-Derived Glioblastoma Cell Lines In Region-Specific Human Brain Organoids

Protocol for Generating in Vitro Glioma Models Using Human-Induced Pluripotent- or Embryonic-Stem-cell-derived Cerebral Organoids.

Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma

The Comparison Genomics Analysis with Glioblastoma Multiforme (GBM) Cells under 3D and 2D Cell Culture Conditions

The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model

Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications

3D Brain Vascular Niche Model Captures Invasive Behavior and Gene Signatures of Glioblastoma

Generating Patient-Derived Gliomas within Cerebral Organoids

Glioblastoma organoid technology: an emerging preclinical models for drug discovery

Glioblastoma-cortical organoids recapitulate cell state heterogeneity and intercellular transfer

The Advancements of Organoids Push the Boundaries of Glioblastoma Research

Novel Brain-Stiffness-Mimicking Matrix Gel Enables Comprehensive Invasion Analysis of 3D Cultured GBM Cells

Behaviors of Glioblastoma Cells in in Vitro Microenvironments

Blood-tumor barrier organoids recapitulate glioblastoma microenvironment and enable high-throughput modeling of therapeutic delivery

Opportunities and challenges of glioma organoids

Organoid Models of Glioblastoma: Advances, Applications and Challenges

Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model